HealthFinSMEsabout 3 hours ago
DropGenie Raises $5M for AI Drug Tools
1 min read
DropGenie, a Cambridge, MA-based functional biology company, raised $5M in Seed+ funding on 26/10/2026. Backers include BDC Thrive Venture Fund, Skeleton Key, Merck Global Health Innovation Fund, CQDM, Real Ventures, and Anges Quebec. The company plans to accelerate commercialization of its automated microfluidic platform for AI-driven drug development.
Level
Hype check
Tap to vote and see what everyone thinks.
